Role of antibodies in developing drugs that target G-protein-coupled receptor dimers
- PMID:20687183
- PMCID: PMC2917817
- DOI: 10.1002/msj.20199
Role of antibodies in developing drugs that target G-protein-coupled receptor dimers
Abstract
G-protein-coupled receptors are important molecular targets in drug discovery. These receptors play a pivotal role in physiological signaling pathways and are targeted by nearly 50% of currently available drugs. Mounting evidence suggests that G-protein-coupled receptors form dimers, and various studies have shown that dimerization is necessary for receptor maturation, signaling, and trafficking. However, the physiological implications of dimerization in vivo have not been well explored because detection of GPCR dimers in endogenous systems has been a challenging task. One exciting new approach to this challenge is the generation of antibodies against specific G-protein-coupled receptor dimers. Such antibodies could be used as tools for characterization of heteromer-specific function; as reagents for their purification, tissue localization, and regulation in vivo; and as probes for mapping their functional domains. In addition, such antibodies could serve as alternative ligands for G-protein-coupled receptor heteromers. Thus, heteromer-specific antibodies represent novel tools for the exploration and manipulation of G-protein-coupled receptor-dimer pharmacology.
2010 Mount Sinai School of Medicine.
Figures
Similar articles
- Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations (Archived).Aleem A, Vaqar S.Aleem A, et al.2023 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2023 Feb 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:34033365Free Books & Documents.
- Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.Ryan R, Hill S.Ryan R, et al.Cochrane Database Syst Rev. 2019 Oct 23;10(10):ED000141. doi: 10.1002/14651858.ED000141.Cochrane Database Syst Rev. 2019.PMID:31643081Free PMC article.
- Evaluating And Referring Patients For Outpatient Monoclonal Antibody Therapy For Coronavirus In The Emergency Department (Archived).Aleem A, Olarewaju O, Pozun A.Aleem A, et al.2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.2023 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.PMID:34662075Free Books & Documents.
- Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.Salisbury L, Baraitser L.Salisbury L, et al.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5.PMID:36137063Free Books & Documents.Review.
- The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.Ostrom RS, Insel PA.Ostrom RS, et al.Br J Pharmacol. 2004 Sep;143(2):235-45. doi: 10.1038/sj.bjp.0705930. Epub 2004 Aug 2.Br J Pharmacol. 2004.PMID:15289291Free PMC article.Review.
Cited by
- Therapeutic antibodies directed at G protein-coupled receptors.Hutchings CJ, Koglin M, Marshall FH.Hutchings CJ, et al.MAbs. 2010 Nov-Dec;2(6):594-606. doi: 10.4161/mabs.2.6.13420. Epub 2010 Nov 1.MAbs. 2010.PMID:20864805Free PMC article.Review.
- Current approaches for the discovery of drugs that deter substance and drug abuse.Yasgar A, Simeonov A.Yasgar A, et al.Expert Opin Drug Discov. 2014 Nov;9(11):1319-31. doi: 10.1517/17460441.2014.956721. Epub 2014 Sep 24.Expert Opin Drug Discov. 2014.PMID:25251069Free PMC article.Review.
- Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function.Gahbauer S, Böckmann RA.Gahbauer S, et al.Front Physiol. 2016 Oct 25;7:494. doi: 10.3389/fphys.2016.00494. eCollection 2016.Front Physiol. 2016.PMID:27826255Free PMC article.Review.
- Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids.Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, Li QF, Jeffry J, Kim JY, Loh HH, Chen ZF.Liu XY, et al.Cell. 2011 Oct 14;147(2):447-58. doi: 10.1016/j.cell.2011.08.043.Cell. 2011.PMID:22000021Free PMC article.
- Contributions of the International Narcotics Research Conference to Opioid Research Over the Past 50 years.Cox BM, Toll L.Cox BM, et al.Adv Drug Alcohol Res. 2022 Feb 18;2:10115. doi: 10.3389/adar.2022.10115. eCollection 2022.Adv Drug Alcohol Res. 2022.PMID:38390618Free PMC article.Review.
References
- Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosc. 2001;2(4):274–286. - PubMed
- Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G-protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol. 2002;42:409–435. - PubMed
- George SR, O'Dowd BF, Lee SP. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov. 2002;1(10):808–20. - PubMed
- Milligan G. Gprotein-coupled receptor dimerization:Function and ligand pharmacology. Mol Pharmacol. 2004;66(1):1–7. - PubMed
- Devi LA. G-protein-coupled receptor dimers in the lime light. Trends Pharmacol Sci. 2000;21(9):324–326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources